| [1] | Wei-Chuan Tsai (2011) Treatment options for hypertension in high-risk patients. Vascular Health and Risk Management 7: 137–141 doi:10.2147/VHRM.S11235. PubMed: 21468174.
|
| [2] | Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358: 1370–1380 doi:10.1056/NEJMra072139. PubMed: 18367740.
|
| [3] | Díez J, Frohlich ED (2010) A translational approach to hypertensive heart disease. Hypertension 55: 1–8 doi:10.1161/HYPERTENSIONAHA.109.141887. PubMed: 19933923.
|
| [4] | Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH (2010) 4-Tiered Classification of Left Ventricular Hypertrophy Based on Left Ventricular Geometry The Dallas Heart Study. Circ Cardiovasc Imaging 3: 164–171 doi:10.1161/CIRCIMAGING.109. 883652. PubMed: 20061518.
|
| [5] | Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117: 568–575 doi:10.1172/JCI31044. PubMed: 17332884.
|
| [6] | Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87: 1285–1342 doi:10.1152/physrev.00012.2007. PubMed: 17928585.
|
| [7] | Si Gao, Zhiping Liu, Hong Li, Peter J Little, Peiqing Liu, et al. (2012) Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 220: 3–10 doi:10.1016/j.atherosclerosis.2011.06.041. PubMed: 21774934.
|
| [8] | Wang P, Wu X, Bao Y, Fang J, Zhou S et al.. (2011) Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P) H oxidase-derived reactive oxygen species production in hypertensive rats. Pharmazie 66: 517–524. PubMed: 21812327.
|
| [9] | Tan X, Li J, Wang X, Chen N, Cai B et al.. (2011) Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Cal-cineurin/Nfatc3 Pathway. Int J Biol Sci 7: 383–389. PubMed: 21494433.
|
| [10] | Feng J, Li SS, Liang QS (2012) Effects of Tanshinone II A on the myocardial apoptosis and the miR-133 levels in rats with heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 930–933. PubMed: 23019950.
|
| [11] | Qiao Z, Ma J, Liu H (2011) Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules 16: 10002–10012 doi:10.3390/molecules161210002. PubMed: 22138858.
|
| [12] | Zhang Y, Zhang L, Chu W, Wang B, Zhang J, et al. (2010) Tanshinone IIA Inhibits miR-1 Expression through p38 MAPK Signal Pathway in Post-infarction Rat Cardiomyocytes. Cell Physiol Biochem 26: 991–998 doi:10.1159/000324012. PubMed: 21220930.
|
| [13] | Yang P, Jia YH, Li J, Li LJ, Zhou FH (2010) Study of anti-myocardial cell oxidative stress action and effect of tanshinone IIA on prohibitin expression. J Tradit Chin Med 30: 259–264. PubMed: 21287782.
|
| [14] | Chan P, Liu JC, Lin LJ, Chen PY, Cheng TH, et al. (2011) Tanshinone IIA Inhibits Angiotensin II-Induced Cell Proliferation in Rat Cardiac Fibroblasts. Am J Chin Med 39: 381–394 doi:10.1142/S0192415X11008890. PubMed: 21476213.
|
| [15] | Xu S, Liu P (2013) Tanshinone IIA: new perspectives for old remedies. Expert Opin Ther Pat 23: 149–153 doi:10.1517/13543776.2013.743995. PubMed: 23231009.
|
| [16] | Crow MT, Mani K, Mani K, Mani K, Kitsis RN (2004) The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957–970 doi:10.1161/01.RES.0000148632. 35500.d9. PubMed: 15539639.
|
| [17] | Fedak PW (2008) Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart. Semin Thorac Cardiovasc Surg 20: 87–93 doi:10.1053/j.semtcvs.2008. 04.001. PubMed: 18707639.
|
| [18] | Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 51: 600–606 doi:10.1016/j. yjmcc.2010.10.033. PubMed: 21059352.
|
| [19] | Amin Shah, Young-Bin Oh, Sun Hwa Lee, Jung Min Lim, Suhn Hee Kim (2012) Angiotensin- (1–7) attenuates hypertension in exercise-trained renal hypertensive rats. Am J Physiol Heart Circ Physiol 302: H2372–H2380 doi:10.1152/ajpheart.00846.2011. PubMed: 22467306.
|
| [20] | Lewis CJ, Gong H, Brown MJ, Harding SE (2004) Overexpression of beta 1-adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for ‘putative’ beta 4-adrenoceptor pharmacology. Br J Pharmacol 141: 813–824 doi:10.1038/sj. bjp.0705668. PubMed: 14757703.
|
| [21] | Davia K, Hajjar RJ, Terracciano CM, Kent NS, Ranu HK et al.. (1999) Functional alterations in adulate rat myocytes after overexpression of phospholamban using adenovirus. Physiol Genomics 1: 41–50. PubMed: 11015560.
|
| [22] | Xiang Jun Zeng, Li Ke Zhang, Hong Xia Wang, Ling Qiao Lu, Li Quan Ma, et al. (2009) Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30: 1144–1152 doi:10.1016/j.peptides.2009.02.010. PubMed: 19463748.
|
| [23] | Martos R, Baugh J, Ledwidge M, O’Loughlin C, Murphy NF, et al. (2009) Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur J Heart Fail 11: 191–197 doi:10.1093/eurjhf/hfn036. PubMed: 19168518.
|
| [24] | Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, et al. (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118: 1433–1441 doi:10.1161/CIRCULATIONAHA.108.783910. PubMed: 18794390.
|
| [25] | Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, et al. (2009) Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 53: 1119–1126 doi:10.1016/j.jacc.2008.11.051. PubMed: 19324256.
|
| [26] | Drazner MH (2011) The progression of hypertensive heart disease. Circulation 123: 327–334 doi:10.1161/CIRCULATIONAHA.108.845792. PubMed: 21263005.
|
| [27] | Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, et al. (2006) Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113: 2089–2096 doi:10.1161/CIRCULATIONAHA.105.573865. PubMed: 16636176.
|
| [28] | Li YS, Yan L, Yong YQ (2010) Effect of tanshinone II A on the transforming growth factor beta1/Smads signal pathway in rats with hypertensive myocardial hypertrophy. Zhongguo Zhong Xi Yi Jie He Za Zhi 30: 499–503. PubMed: 20681280.
|
| [29] | Zhou DX, Liang QS, He XX, Zhan CY (2008) Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A. Zhongguo Zhong Yao Za Zhi 33: 936–939. PubMed: 18619357.
|
| [30] | HONG HJ, LIU JC, CHENG TH, CHAN P (2010) Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes. Acta Pharmacol Sin 31: 1569–1575 doi:10.1038/aps.2010.176. PubMed: 21102479.
|
| [31] | Wang ZH, Liang QS, Zheng Z (2009) The Effect of Tanshinone on Myocardial Hypertrophy Induced by High Salt Diet. Acta Med Univ Sei Technol Huazhong 38: 500–503.
|
| [32] | Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM (2011) Redox signaling in cardiac myocytes. Free Radic Biol Med 50: 777–793 doi:10.1016/j.freeradbiomed. 2011.01. 003. PubMed: 21236334.
|
| [33] | Sadoshima J (2006) Redox regulation of growth and death in cardiac myocytes. Antioxid Redox Signal 8: 1621–1624 doi:10.1089/ars.2006.8.1621. PubMed: 16987016.
|
| [34] | Ekhterae D, Hinmon R, Matsuzaki K, Noma M, Zhu W, et al. (2011) Infarction induced myocardial apoptosis and ARC activation. J Surgical Res 166: 59–67 doi:10.1016/j.jss. 2009.05.002. PubMed: 19815236.
|
| [35] | Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: Mechanisms and significance. Annu Rev Physiol 72: 19–44 doi:10.1146/annurev. physiol. 010908.163111. PubMed: 20148665.
|
| [36] | Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437–441 doi:10.1242/jcs.031682. PubMed: 19193868.
|
| [37] | Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, et al. (2012) Interleukin-17A Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Cardiomyocyte Apoptosis and Neutrophil Infiltration. J Am Coll Cardiol 59: 420–429 doi:10.1016/j.jacc.2011.10.863. PubMed: 22261166.
|
| [38] | Iturrioz X, El Messari S, De Mota N, Fassot C, Alvear-Perez R, et al. (2007) Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. Archives des maladies du coeur et des vaisseaux 100: 704–708 doi:AMCV-08-2007-100-8-0003-9683-101019-2006？00023.PubMed: 17928781.
|
| [39] | Langelaan DN, Reddy T, Banks AW, Dellaire G, Dupre DJ, et al. (2013) Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking. Biochimica et biophysica acta 1828: 1471–1483 doi:10. 1016/j.bbamem.2013.02.005. PubMed: 23438363.
|
| [40] | Iturrioz X, Alvear-Perez R, De Mota N, Franchet C, Guillier F, et al. (2010) Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. Faseb J 24: 1506–1517 doi:10.1096/fj.09-140715. PubMed: 20040517.
|
| [41] | Zhang Z, Yu B, Tao GZ (2009) Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chinese medical journal 122: 2360–2365 doi:10.3760/cma.j.issn.0366-6999.2009.19.031？.PubMed: 20079140.
|
| [42] | Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89: 265–272 doi:10.1093/cvr/cvq308. PubMed: 20880837.
|
| [43] | Gradman AH, Wilson JT (2009) Hypertension and diastolic heart failure. Curr Cardiol Rep 11: 422–429 doi:10.1007/s11886-009-0061-5. PubMed: 19863866.
|
| [44] | Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, et al. (2005) Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure- overloaded human heart. Circulation 112: 1136–1144 doi:10.1161/CIRCULATIONAHA. 104.516963. PubMed: 16103240.
|
| [45] | Dixon JA, Spinale FG (2011) Myocardial remodeling: cellular and extracellular events and targets. Annu Rev Physiol 73: 47–68 doi:10.1146/annurev-physiol-012110-142230. PubMed: 21314431.
|
| [46] | Spinale FG, Koval CN, Deschamps AM, Stroud RE, Ikonomidis JS (2008) Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion. Circulation 118: S16–S23 doi:10.1161/CIRCULATIONAHA.108.786640. PubMed: 18824748.
|
| [47] | Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, et al. (2010) TIMP2 deficiency accelerates adverse postmyocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res 106: 796–808 doi:10.1161/CIRCRESAHA.109.209189. PubMed: 20056917.
|
| [48] | Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803: 55–71 doi:10. 1016/j.bbamcr.2010.01.003. PubMed: 20080133.
|
| [49] | Fang J, Xu SW, Wang P, Tang FT, Zhou SG, et al. (2010) Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. Phytomedicine 18: 58–64 doi:10.1016/j.phymed.2010.06.002. PubMed: 20638255.
|
| [50] | Song Y, Xu J, Li Y, Jia C, Ma X, et al. (2012) Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways. PLOS ONE 7: e50436 doi:10.1371/journal.pone.0050436. PubMed: 23227174.
|
| [51] | Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389–395 doi:10.1038/74651. PubMed: 10742145.
|
| [52] | Chen CH, Poucher SM, Lu J, Henry PD (2004) Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2: 33–43 doi:10.2174/1570161043476500. PubMed: 15320831.
|
| [53] | Narine K, De Wever O, Van Valckenborgh D, Francois K, Bracke M, et al. (2006) Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng 12: 2707–2716 doi:10.1089/ten.2006.12.2707. PubMed: 17518640.
|
| [54] | Suzuki T, Akasaka Y, Namiki A, Ito K, Ishikawa Y, et al. (2008) Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats. J Hypertens 26: 2436–2444 doi:10.1097/HJH.0b013e328312c889. PubMed: 19008723.
|
| [55] | Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S (2012) TGF-β - an excellent servant but a bad master. J Transl Med 10: 183 doi:10.1186/1479-5876-10-183. PubMed: 22943793.
|
| [56] | Li Y, Yang Y, Yu D, Liang Q (2009) The effect of tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats. J Huazhong Univ Sci Technolog Med Sci 29: 476–480 doi:10.1007/s11596-009-0417-5. PubMed: 19662366.
|
